Product Description

Overview: What is PT-141 (Bremelanotide)?

PT-141 (Bremelanotide) is a synthetic peptide developed as an analog of alpha-Melanocyte Stimulating Hormone ($\alpha$-MSH). It functions as an agonist to melanocortin receptors (specifically MC1 and MC4) in the nervous system.

Unlike traditional sexual health medications (such as Viagra or Cialis) which primarily affect the vascular system (blood flow), PT-141 acts directly on the brain to increase arousal and libido. This unique mechanism makes it effective for treating sexual dysfunction in both men and women.

While its primary use is for sexual health, research is ongoing regarding its potential benefits for depression, chronic pain, and hormonal imbalances.

---

Key Benefits

PT-141 is highly valued for its ability to restore intimacy and confidence. Its benefits include:

• Libido & Desire: Significantly increases sexual appetite and desire in both sexes.

• Erectile Function (Men): Improves the quality and duration of erections by enhancing circulation to the genital organs.

• Sensation (Women): effectively treats female sexual dysfunction (FSD) by improving physical arousal and increasing the intensity of orgasms.

• Psychological Well-being: Boosts self-esteem and confidence related to sexual performance. It may also help alleviate fear and anxiety associated with PTSD without causing artificial euphoria.

• Fast Acting: Effects are typically felt within hours of administration and can last for extended periods.

---

Insights from Clinical Trials

PT-141 has undergone various studies confirming its efficacy for sexual dysfunction:

• Women (2000 Study): Dr. Hyla Cass conducted a trial where women treated with PT-141 reported significantly higher levels of sexual desire and satisfaction compared to the placebo group.

• Men (2004 Study): A study of men with erectile dysfunction (ED) showed that PT-141 resulted in higher sexual stimulation and more durable erections.

• Large Scale (2010 Study): Published in the Journal of Sexual Medicine, a trial involving 327 women demonstrated that PT-141 successfully improved sexual satisfaction, desire, and overall activity levels.

---

Dosage and Administration Protocol

Note: The following instructions are based on the 10mg Pen.

Dosage Protocols:

PT-141 is flexible. The onset of effects is usually 1 to 6 hours after injection, and effects can last up to 30+ hours.

• Protocol A (Split Dose): Inject 8 units the night before planned activity, followed by 5 units the next morning.

• Protocol B (Single Dose): Inject 10–12 units approximately 4–6 hours before planned sexual contact.

Using the Pen (Concentration: 200 units per pen / 50mcg per unit):

• Dial Setting: Set the pen dial based on your chosen protocol (e.g., 10 units).

• Injection Technique: Inject subcutaneously into the abdomen or thigh.

• Wait Time: Hold the needle for 10 seconds after injecting. Rotate injection sites.

Conversion Reference (10mg Pen):

• 1 unit = 50 mcg

• 5 units = 250 mcg

• 8 units = 400 mcg (Starting Dose)

• 10 units = 500 mcg (Standard Dose)

• 12 units = 600 mcg

• 15 units = 750 mcg

---

Synergistic Combinations (Stacking)

To enhance effects, PT-141 is often combined with other peptides:

1. Melanotan II: Since PT-141 is a derivative of Melanotan, stacking them can create a potent synergistic effect for maximum libido and arousal (along with tanning effects).

2. Ipamorelin: A growth hormone secretagogue. Combining this with PT-141 improves energy, stamina, and physical endurance, complementing the sexual health benefits.

---

Safety and Side Effects

PT-141 is effective but has a distinct side effect profile that users should be aware of.

Possible Side Effects:

• Nausea: This is the most common side effect (often subsides after the first few uses).

• Flushing: Redness or warmth in the face/neck.

• Headaches: Mild headaches may occur.

• Blood Pressure: A slight, temporary increase in blood pressure may occur.

• Local: Mild irritation at the injection site.

Side effects are generally mild and temporary. It is recommended to start with a lower dose to assess tolerance.